Goldman Sachs resets Pfizer stock forecast
Pfizer has spent the past few years trying to convince investors that its post-pandemic business can stand on its own, and Goldman Sachs
Pfizer has spent the past few years trying to convince investors that its post-pandemic business can stand on its own, and Goldman Sachs
Mezo Prime is intended for businesses that own Bitcoin but have few ways to use it. Bitcoin kept in an Enclave may be
Celestica (CLS) just erased nearly $10 billion in market value in a single day, sending shares down about 16% after earnings. On the
SoFi Technologies enters its next earnings report with something many fintech companies would like to have: a clear growth story, improving profitability and
Marcus Lemonis has never been a quiet operator. Since taking over as CEO of Bed Bath & Beyond on Jan. 1, he has
On Monday, the Crypto Fear & Greed Sentiment Index hit 47, marking its first “Neutral” reading in three months. According to Farside, the
Anyone may verify Block’s holdings independently using on-chain signatures, according to Block. Even though they are the largest corporation in the world holding
SanDisk has been one of the most extraordinary stock stories of 2026. Up nearly 295% year to date, the memory chip company has
The next arms race is not playing out in submarines or stealth jets. It is happening in the sky above your local stadium.
Nobody announced a sweeping retirement overhaul. There was no single bill that changed everything overnight. But piece by piece, the policy landscape for